Skip to Main Content

Paper Details

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust.
Eur J Heart Fail
161
2020
ACE2, Angiotensin-converting enzyme, COVID-, COVID-19, COVID-19 infection, Patients, SARS-CoV, SARS-CoV-2, angiotensin II, angiotensin II receptor, angiotensin-converting enzyme, angiotensin-converting enzyme 2, diabetes, hypertension, patients
Author NameAffiliation
Amos A FolarinInstitute of Psychiatry, King's College London
Amos A FolarinUniversity College London
Amos A FolarinInstitute of Health Informatics, University College London
Amos A FolarinNIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust
James T TeoKing's College Hospital NHS Foundation Trust
James T TeoInstitute of Psychiatry, King's College London
Richard J B DobsonInstitute of Psychiatry, King's College London
Richard J B DobsonUniversity College London
Richard J B DobsonNIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London
Richard J B DobsonInstitute of Health Informatics, University College London
Richard J B DobsonNIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust
Richard J B DobsonInstitute of Psychiatry, King's College London
Richard J B DobsonUniversity College London
Richard J B DobsonNIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London
Richard J B DobsonInstitute of Health Informatics, University College London
Richard J B DobsonNIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust
  • 1 - 16

Datasets

Release 1.2